• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝叶斯方法用于质量公差限 (QTL) 监测。

Bayesian Methods for Quality Tolerance Limit (QTL) Monitoring.

机构信息

Data Science, Astellas Pharma Global Development, Inc, Northbrook, Illinois, USA.

Department of Statistics, George Mason University, Fairfax, Virginia, USA.

出版信息

Pharm Stat. 2024 Nov-Dec;23(6):1166-1180. doi: 10.1002/pst.2427. Epub 2024 Aug 9.

DOI:10.1002/pst.2427
PMID:39119894
Abstract

In alignment with the ICH guideline for Good Clinical Practice [ICH E6(R2)], quality tolerance limit (QTL) monitoring has become a standard component of risk-based monitoring of clinical trials by sponsor companies. Parameters that are candidates for QTL monitoring are critical to participant safety and quality of trial results. Breaching the QTL of a given parameter could indicate systematic issues with the trial that could impact participant safety or compromise the reliability of trial results. Methods for QTL monitoring should detect potential QTL breaches as early as possible while limiting the rate of false alarms. Early detection allows for the implementation of remedial actions that can prevent a QTL breach at the end of the trial. We demonstrate that statistically based methods that account for the expected value and variability of the data generating process outperform simple methods based on fixed thresholds with respect to important operating characteristics. We also propose a Bayesian method for QTL monitoring and an extension that allows for the incorporation of partial information, demonstrating its potential to outperform frequentist methods originating from the statistical process control literature.

摘要

根据 ICH 指导原则良好临床规范[ICH E6(R2)],质量公差限(QTL)监测已成为赞助商公司基于风险的临床试验监测的标准组成部分。对于 QTL 监测候选的参数对参与者的安全性和试验结果的质量至关重要。违反给定参数的 QTL 可能表明试验中存在系统性问题,这些问题可能影响参与者的安全性或损害试验结果的可靠性。QTL 监测方法应尽早发现潜在的 QTL 突破,同时限制误报率。早期检测允许实施补救措施,以防止试验结束时出现 QTL 突破。我们证明,考虑到数据生成过程的预期值和变异性的基于统计学的方法在重要的操作特性方面优于基于固定阈值的简单方法。我们还提出了一种用于 QTL 监测的贝叶斯方法及其扩展,允许纳入部分信息,证明了其在性能上优于源自统计过程控制文献的频率方法的潜力。

相似文献

1
Bayesian Methods for Quality Tolerance Limit (QTL) Monitoring.贝叶斯方法用于质量公差限 (QTL) 监测。
Pharm Stat. 2024 Nov-Dec;23(6):1166-1180. doi: 10.1002/pst.2427. Epub 2024 Aug 9.
2
Quality Tolerance Limits: Framework for Successful Implementation in Clinical Development.质量容忍限度:临床开发中成功实施的框架。
Ther Innov Regul Sci. 2021 Mar;55(2):251-261. doi: 10.1007/s43441-020-00209-0. Epub 2020 Sep 3.
3
An Overview of Current Statistical Methods for Implementing Quality Tolerance Limits.现行质量公差限实施统计方法概述。
Ther Innov Regul Sci. 2024 Mar;58(2):273-284. doi: 10.1007/s43441-023-00598-y. Epub 2023 Dec 26.
4
Determining the extent and frequency of on-site monitoring: a bayesian risk-based approach.确定现场监测的范围和频率:一种基于贝叶斯风险的方法。
BMC Med Res Methodol. 2024 Jun 28;24(1):141. doi: 10.1186/s12874-024-02261-y.
5
Quality Tolerance Limits: A General Guidance for Parameter Selection and Threshold Setting.质量公差限:参数选择和阈值设定的一般指南。
Ther Innov Regul Sci. 2024 May;58(3):423-430. doi: 10.1007/s43441-024-00617-6. Epub 2024 Feb 6.
6
Optimizing Quality Tolerance Limits Monitoring in Clinical Trials Through Machine Learning Methods.通过机器学习方法优化临床试验中的质量公差限度监测
Ther Innov Regul Sci. 2025 May;59(3):566-578. doi: 10.1007/s43441-025-00754-6. Epub 2025 Feb 25.
7
Bayesian designs and the control of frequentist characteristics: a practical solution.贝叶斯设计与频率论特征的控制:一种实用解决方案。
Biometrics. 2015 Mar;71(1):218-226. doi: 10.1111/biom.12226. Epub 2014 Sep 5.
8
A decision-theoretic approach to Bayesian clinical trial design and evaluation of robustness to prior-data conflict.一种决策理论方法在贝叶斯临床试验设计中的应用及对先验数据冲突稳健性的评估。
Biostatistics. 2022 Jan 13;23(1):328-344. doi: 10.1093/biostatistics/kxaa027.
9
Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.基于二次损失函数的贝叶斯决策理论组序贯临床试验设计:频率学派评估
Clin Trials. 2007;4(1):5-14. doi: 10.1177/1740774506075764.
10
Estimating the Sampling Distribution of Posterior Decision Summaries in Bayesian Clinical Trials.贝叶斯临床试验中后验决策总结的抽样分布估计。
Biom J. 2024 Dec;66(8):e70002. doi: 10.1002/bimj.70002.